Investing in AzurRx BioPharma, Inc.? If so, we recommend checking out these offers as well (we believe these to be much more interesting):
Cannabis Trader: https://logistics-business-review.com/cannabis-trader-for-AZRX-investors
Trade Netflix: https://logistics-business-review.com/netflix-for-AZRX-investors
Wall Street Journal: https://logistics-business-review.com/wsj-for-AZRX-investors (only $12 for 12 weeks – everyone should get this)
REPORTING FOR 2019-07-29 | LOGISTICS-BUSINESS-REVIEW.COM: We have conducted a deep analysis of how AzurRx BioPharma, Inc. ($AZRX) has been trading over the last 2 weeks and the past day especially. On its latest session, AzurRx BioPharma, Inc. ($AZRX) opened at 1.02, reaching a high of 1.03 and a low of 0.99 before closing at a price of 1.0. There was a total volume of 233305.
VOLUME INDICATORS: We saw an accumulation-distribution index of 9.09368, an on-balance volume of 1.02, chaikin money flow of 7.0 and a force index of 0.0004. There was an ease of movement rating of -0.00027, a volume-price trend of -0.48799 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 0.10972, bolinger bands of 1.04743, an upper bollinger band of 0.96257, lower bollinger band of 0.99, a bollinger high band indicator of 1.0, bollinger low band indicator of 1.0, a central keltner channel of 1.01333, high band keltner channel of 1.00333, low band keltner channel of 1.02333, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 0.99, a donchian channel low band of 0.99, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of 0.00067, a MACD signal of 0.00037, a MACD difference of 0.0003, a fast Exponential Moving Average (EMA) indicator of 0.99, a slow Exponential Moving Average (EMA) indicator of 0.99, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.02933, a trix of -42.9626, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of 0.97613, a KST Oscillator (KST) of -496.47302 and a KST Oscillator (KST Signal) of -496.47302 (leaving a KST difference of 3.8146). We also found an Ichimoku rating of 1.025, an Ichimoku B rating of 1.025, a Ichimoku visual trend A of 2.01916, an Ichimoku visual trend B of 1.82622, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of 4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 50.97549, a True Strength Index (TSI) of -100.0, an ultimate oscillator of -4.27291, a stochastic oscillator of 400.0, a stochastic oscillator signal of 400.0, a Williams %R rating of 300.0 and an awesome oscillator of 0.00782.
RETURNS: There was a daily return of -49.6473, a daily log return of 2.9853 and a cumulative return of 3.0303.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-29 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for AzurRx BioPharma, Inc. ($AZRX)…
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on AzurRx BioPharma, Inc., we strongly advise AzurRx BioPharma, Inc. investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like AzurRx BioPharma, Inc. – without this you are trading blind:
We will of course continue to cover the news and price action of AzurRx BioPharma, Inc., but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling AzurRx BioPharma, Inc. ($AZRX) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.
Latest posts by Gary Ivenchuck (see all)
- New Analysis: Virtusa Corporation ($VRTU) vs CarGurus, Inc. ($CARG) - August 20, 2019
- DNB Financial Corp ($DNBF) Takes On HomeStreet, Inc. ($HMST) - August 20, 2019
- Viper Energy Partners LP ($VNOM) Takes On Extraction Oil & Gas, Inc. ($XOG) - August 20, 2019